Acute myeloblasts leukaemia with alternations of MLL proto-oncogene protein (⌉⌉q23/MLL+ AML);Akútna myeloblastová leukémia s alteráciami MLL protoonkogénu (⌉⌉q23/MLL+AML)

Klinicka Onkologie

Volumn 23, Issue 6, 2010, Pages 401-407

  Mikulasova Z ^a   Ilencikova D ^a,b   Slamka, T ^a   Durovcikova D ^b  

^a Oddelenie Onkologickej Genetiky   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Acute myeloid leukaemia; Chromosomal translocations; Mll proto oncogene protein

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR C MAF;

ACUTE MYELOBLASTIC LEUKEMIA; CANCER INCIDENCE; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME REARRANGEMENT; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE TRANSLOCATION; HUMAN; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

CHROMOSOMES, HUMAN, PAIR 11; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; MYELOID-LYMPHOID LEUKEMIA PROTEIN; TRANSLOCATION, GENETIC;

EID: 78650631726     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Jabbour EJ, Estey E, Kantarjian HM et al. Adult Acute Myeloid Leukemia. Mayo Clin Proc 2006, 81 (2): 247-260.
2. Pedersen-Bjergaard J, Christiansen DH, Andersen MK et al. Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities. Leukemia 2002; 16(11): 2177-2184. (Pubitemid 35331831)
3. Schoch C, Schnittger S, Klaus M et al. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003,102(7):2395-2402.
4. Haferlach T, Schoch C, Schnittger S et al. Distinct genetic patterns can be identified in acute monoblasts and acute monocytic leukaemia (FAB AML M5a and M5b): a study of 124 patients. Br J Haematol 2002; 118(2): 426-431.
5. Arnaud B, Douet-Guilbert N, Morel F et al. Screening by fluorescent in situ hybridization for MLL status at diagnosis in 239 unselected patients with acute myeloblasts leukemia. Cancer Genet Cytogenet 2005; 161 (2): 110-115.
6. COX MC, Panetta R Lo-Coco F et al. Chromosomal Aberration of the 11q23 Locus in Acute Leukemia and Frequency of MLL Gene Translocation, results in 378 adult patients Am J Clin Pathol 2004; 122(2): 298-306.
7. Alcalay M, Meani N, Gelmetti V et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J Clim Invest 2003; 112(11):1751-1761.
8. Armstrong SA, Staunton JE, Silverman LB et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30(1): 41-47.
9. Cimino G, Rapanotti MC, Sprovieri T et al. All 1 gene alternations in Acute leukemia: biological and clinical aspects. Haematologica 1998; 83(4): 350-357.
10. Wakui M, Kuriyama K, Miyazaki Y et al. Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol. Int J Hematol 2008; 87(2)-144-151
11. Broeker PL, Super HG, Thirman MJ et al Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 1996:87(5): 1912-1922.
12. Giampaolo A, Felli N, Diveno D et al. Expression pattern of HOXB6 homeobox gene in myelomonocytic differentiation and acute myeloid leukemia. Leukemia 2002; 16(7): 1293-1301.
13. Meyer C, Kowarz E, Hofmann J et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009; 23(8): 1490-1499.
14. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001; 20(40): 5695-5707.
15. Whitman SP, Liu S, Vukosavljevic T et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy Blood 2005; 106(1): 345-352.
16. Libura M, Asnafi V, Tu A et al. FLT3 and MLL intragenic abnormalities In AMLreflect a common category of genotoxic stress. Blood 2003; 102(6). 2198-2204.
17. Caligiuri MA, Strout M, Lawrence D et al. Rearrangement of ALL1 [MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998; 58(1): 55-59.
18. Schnittger S, Kinkelin U, Schoch C et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 2000; 14(5): 796-804.
19. Tanaka K, Takechi M, Nishimura S et al. Amplification of the c-MYC oncogene and point mutation of N-RAS oncogene in acute myelocytic leukemia with double minute chromosomes. Leukemia 1993; 7(3): 469-473.
20. Andersson A, Hoglund M, Johansson B et al. Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies. Leukemia 2001; 15(8): 1293-1300.
21. Rego EM. Molecular basis of Acute myelogenous Leukemia. Rev bras hematol hemoter 2002; 24(3): 163.
22. Gene Cards. The Human Gene Compendium. MLL Gene. Dostupné z http://www.genecards.org/cgi-bin/carddisp.pl?gene=MLL&search=MLL.